We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A group of Iraq War veterans and their families filed a lawsuit this week accusing several drugmakers of contributing to servicemembers’ deaths by indirectly funding militias in Iraq. Read More
Sen. Claire McCaskill (D-Mo.) introduced a bill that would repeal 2016 legislation that she believes weakened the Drug Enforcement Administration’s ability to go after opioid distributors. Read More
A shift to more expensive settings can mean higher costs for Medicare beneficiaries and privately insured patients who pay a portion of the treatment charges. Read More
According to the complaint, the labels understate the percentage of users the symptoms effect at only 1 or 2 percent, when in fact it is closer to 50 percent. Read More
The FDA’s draft guidance on post-approval manufacturing changes for biological products needs work to clarify how it fits with previous agency documents, according to written comments on the draft, which were due last week. Read More